Henrik is a Partner at Stirling Square Capital Partners, based in London. Henrik has 20 years of experience in private equity including 4 years as President & CEO of CPS Color Group Oy in Helsinki. He is currently a board member of Logent AB (publ), Assistansbolaget AB and Zengun Group AB (publ) in Sweden and Vision Ophtalmology Group in Germany. Henrik holds an MSc in Mechanical Engineering from the Royal Institute of Technology in Stockholm and an MSC in Business Administration from the Stockholm School of Economics.
Naveen is a Partner and co-head of the European Technology Group at TA Associates. He joined the firm in 2001 and focuses on investments in growth companies globally. Naveen currently serves on the Board of Directors of Compusoft, RLDatix, Ideal Cures, IFS AB, Interswitch, Priority Software and RateGain. Prior to joining TA, Naveen worked in the M&A Group at Broadview International, as a member of the Special Situations Group at Goldman Sachs, and as a Senior Associate at Accretive LLC. Naveen received a BSc degree in Systems Engineering from the University of Pennsylvania and an MBA degree from the Wharton School of Business.
Raphael is an Investment Executive at Stirling Square Capital Partners, based in London. He is currently a board member of Logent AB (publ) and Assistansbolaget AB in Sweden as well as Vision Ophthalmology Group in Germany. Raphael has previously worked for McKinsey & Company and holds a BSc and MSc from WHU (Otto Beisheim School of Management) and an MBA from Harvard Business School.
Max is a Principal at TA Associates. He is based in London and joined TA in 2010. He currently also serves on the board of Interswitch in Nigeria and Netrisk Group in Hungary, and is a board observer of ITRS in the UK and IFS in Sweden. Prior to joining TA, he worked in the Investment Banking Division at Barclays Capital. Max received a BA degree from the University of Pennsylvania and an MBA degree from the Harvard Business School.